Arlington, Virginia-based LiveSafe, a provider of a risk intelligence technology platform, has secured $11 million in funding. The investors included Hearst, Enterprise Investment Partners, IAC, Revolution's Rise of the Rest Seed Fund, GXPI and the Kilberg family.
1 min read · 27 September 2018
SeventySix Capital, a sports-focused venture firm, has added NBA Hall of Famer Ralph Sampson to its athlete venture group. In his new role, Sampson will work hands-on with the company’s current sports tech fund. During his career, Sampson played for the Houston Rockets.
4 min read · 27 September 2018
The Alexa Fund has made investments in three early-stage voice startups Bamboo Learning, Endel and Aiva, according to a post. No financial terms were disclosed. The Alexa Fund provides up to $100 million in venture funding for voice technology.
1 min read · 27 September 2018
SoloLearn, a global coding community, has raised $5.6 million in funding. Naspers led the round with participation from return backer Learn Capital.
4 min read · 27 September 2018
New York City-based Compass, a real estate technology company, has raised $400 million in Series F financing. The Softbank Vision Fund and Qatar Investment Authority led the round with participation from Wellington, IVP and Fidelity.
1 min read · 27 September 2018
Arrowroot Capital is seeking to raise $315 million for its fourth fund, according to an SEC filing. Santa Monica, California-based Arrowroot Capital Management is a growth equity firm that invests in B2B software firms.
1 min read · 27 September 2018
NovaQuest Capital Management has raised over $95 million for its debut private equity fund, according to an SEC filing. The target is $400 million. Based in Raleigh, North Carolina, NovaQuest invests in the life sciences and healthcare sector.
1 min read · 27 September 2018
Detroit-based Guardhat, an internet of things industrial safety technology developer, has raised $20 million in Series A funding. RTP Ventures led the round with participation from 3M Ventures, Caterpillar Venture Capital, Revolution's Rise of the Rest Seed Fund, SVB and DVP.
1 min read · 27 September 2018
South San Francisco-based Sutro Biopharma Inc, a drug developer focused on creating protein therapeutics for cancer and autoimmune disorders, has raised about $85 million after pricing its over 5.6 million shares at $15 per share. The stock began trading September 27, 2018 on the NASDAQ under the ticker symbol "SRO." Cowen and Piper Jaffray are the lead underwriters. Also, Sutro has raised about $10 million in a private placement from Merck. Sutro's pre-IPO investors included Samsara BioCapital, Surveyor Capital, Alta Partners, Amgen Ventures, Celgene Corporation, Lilly Ventures, Skyline Ventures and SV Health Investors.
2 min read · 27 September 2018
New Haven, Connecticut-based Arvinas Inc, a biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases, has raised about $120 million after pricing its IPO of 7.5 million shares at $16 per share. The stock began trading September 27, 2018 on the NASDAQ under the ticker symbol “ARVN." Goldman Sachs, Citigroup and Piper Jaffray & Co are the lead underwriters. Arvinas' pre-IPO backers included Nextech Invest, Deerfield Management, Hillhouse Capital, Sirona Capital, Canaan Partners, 5AM Ventures, RA Capital Management, OrbiMed and New Leaf Venture Partners.
3 min read · 27 September 2018
